Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.91
Delayed Data
As of 3:52pm ET
 +0.06 / +2.11%
Today’s Change
1.93
Today|||52-Week Range
3.55
+37.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues444.4M585.0M585.1M239.7M
 
 
 
 
 
Cost of Goods Sold0.00----4.1M
 
 
Depreciation And Amortization5.6M----12.0M
 
 
 
 
Operating ExpensesGross Income438.8M----223.6M
 
 
 
General Expenses29.8M34.9M36.1M44.1M
 
 
 
 
 
Other Operating Expenses0.000.004.0M0.00
 
 
Research And Development------3.8M
 
 
Total Operating Expenses35.4M34.9M40.1M60.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income409.0M550.1M545.0M179.4M
 
 
 
 
 
Extraordinary Credit0.000.006.5M6.5M
 
 
 
Extraordinary Charge0.00-6.1M---60.7M
 
 
 
Interest Expense On Debt24.9M39.2M27.1M20.8M
 
 
 
 
 
Other Expenses-1.5M-3.8M5.8M4.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income401.9M501.3M530.1M109.4M
 
 
 
 
 
Income Taxes-137.3M-179.0M-197.3M-45.7M
 
 
 
 
 
Minority Interest0.000.000.00-53.0K
 
 
Net Income264.5M322.2M332.8M63.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS139.8M158.2M163.4M163.8M
 
 
 
 
 
Shares To Calculate EPS Diluted159.3M173.1M163.6M164.2M
 
 
 
 
 
 
Earnings Per ShareEPS$1.66$1.86$2.03$0.39
 
 
 
 
 
EPS Diluted$1.66$1.86$2.03$0.39